Mechanisms of ventricular arrhythmias in the presence of pathological hypertrophy
Related Experiment Video
Updated: Jun 23, 2026

Isolation and Functional Characterization of Human Ventricular Cardiomyocytes from Fresh Surgical Samples
Published on: April 21, 2014
J Cosín Aguilar1, A Hernandiz Martinez, F Andres Conejos
1Centro Investigacion, Hospital La Fe, Valencia, Spain.
Insights
Left ventricular hypertrophy (LVH) increases ventricular arrhythmias and sudden death risk. Mechanisms involve electrical changes, collagen, and ischemia, contributing to arrhythmias in LVH patients.
Area of Science:
- Cardiology
- Electrophysiology
- Pathophysiology
Background:
- Left ventricular hypertrophy (LVH) is associated with an increased incidence of ventricular arrhythmias.
- LVH is a recognized risk factor for sudden cardiac death.
- The direct link between malignant arrhythmias in LVH and sudden death remains unclear.
Purpose of the Study:
- To explore the arrhythmogenic substrate in patients with left ventricular hypertrophy.
- To identify factors contributing to the increased risk of arrhythmias in LVH.
Main Methods:
- The study discusses the arrhythmogenic substrate in LVH, focusing on contributing factors and mechanisms.
- Analysis of electrical changes, collagen matrix growth, and ischemia in hypertrophic myocytes.
- Examination of reentry mechanisms and after-potential triggers.
Main Results:
- Ventricular extrasystoles and complex ventricular arrhythmias are more prevalent in LVH.
- Factors like hypertension, myocyte electrical changes, fibrosis, and ischemia contribute to arrhythmias.
- The arrhythmogenic substrate involves reentry due to fibrillar stretching/anisotropy and calcium channel-dependent after-potentials.
Conclusions:
- LVH creates an arrhythmogenic substrate predisposing to ventricular arrhythmias.
- Multiple factors, including electrical remodeling and ischemia, contribute to arrhythmia generation in LVH.
- Understanding these mechanisms is crucial for managing sudden death risk in LVH patients.
Abstract:
Ventricular extrasystoles and the complex forms of non-malignant ventricular arrhythmias clearly increase in the presence of left ventricular hypertrophy. Left ventricular hypertrophy constitutes a clear sudden death risk factor. The connection between possible malignant arrhythmias, which have also been reported in LVH patients, and an increased incidence of sudden death has not been established. Hypertension, electrical changes in the hypertrophic myocyte, the growth of the collagen matrix and ischaemia (even in the absence of macro-angiographic injuries) are factors present in this group of patients that contribute to the appearance of arrhythmias. The arrhythmogenic substrate of LVH has to do with reentry mechanisms due to fibrillar stretching and anisotropy, as well as with self-sustaining activity triggered by after-potentials that depend on activation of slow calcium channels.
Related Concept Videos
Mechanism of Cardiac Arrhythmias
Pathophysiology of Cardiac Performance
Pathophysiology of Heart Failure
Heart Failure II: Pathophysiology
Cardiomyopathy I: Introduction and Classification
Cardiomyopathy III: Hypertrophic Cardiomyopathy

